Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,165.08
(
0.80%
)
US TECH 100
26,538.40
(
1.85%
)
Dow Jones
49,247.66
(
-0.13%
)
Brent Oil
100.66
(
0.00%
)
Bitcoin
77,531.95
(
0.08%
)
News Focus
News Focus
Post# of 822859
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Galzus Research

Send PM Follow Ignore
Followers 1
Posts 430
Boards Moderated 0
Alias Born 12/14/2024

Galzus Research

Re: Jackxkr post# 765741

Saturday, 05/03/2025 5:49:04 PM

Saturday, May 03, 2025 5:49:04 PM

Post# of 822859
I don’t know why anyone here is hostile to TTF. It has equally strong data of improving OS with its own controversial interpretations

But TTF is completely not in conflict with DC immunotherapy. There is no reason that a patient getting DCVax couldn’t get TTF as well.

So I agree, but DCVax is an iterative improvement on GBM care, and TTF is also. No reason they wouldn’t both be used.
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News